Literature DB >> 31424668

Association of low Syndecan-1 expression with adverse histopathological parameters in gastric carcinomas.

Antonia Charchanti1, Alexandra Papoudou Bai, Epaminontas Samantas, Pavlos Papakostas, Pantelis Skarlos, Panagiotis Kanavaros, Georgios Ntritsos, Niki J Agnantis, Anna C Goussia.   

Abstract

PURPOSE: Since syndecan-1 is an adhesion molecule involved in tumor invasion and metastasis, we evaluated the relationship between syndecan-1 expression and histopathological features of gastric carcinomas.
METHODS: Syndecan-1 expression was evaluated in 104 gastric carcinomas using immunohistochemistry.
RESULTS: High, moderate and low syndecan-1 expression in carcinoma cells was observed in 17/104, 25/104 and 62/104 cases, respectively. High, moderate and low syndecan-1 expression in stromal cells was observed in 5/104, 22/104 and 77/104 cases, respectively. Low epithelial syndecan-1 expression was significantly associated with increased depth of invasion (p=0.034) and lymph vessel invasion (p=0.035). Low stromal syndecan-1 expression was significantly associated with histologic type (intestinal vs diffuse/mixed; p=0.04), increased histologic grade (p=0.04) and large tumor size (p=0.026).
CONCLUSION: Low levels of tumor and stromal syndecan- 1 expression were associated with adverse histopathological parameters in gastric carcinoma. This suggests that syndecan-1 expression may be helpful for assessing the aggressiveness of gastric carcinomas.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31424668

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  4 in total

1.  Expression of Syndecan-1 in Chronic Liver Diseases: Correlation With Hepatic Fibrosis.

Authors:  Antonia Charchanti; Panagiotis Kanavaros; Efthymios Koniaris; Agapi Kataki; Georgios Glantzounis; Niki J Agnantis; Anna C Goussia
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Loss of expression of Syndecan-1 is associated with Tumor Recurrence, Metastatic Potential, and Poor Survival in patients with Colorectal carcinoma.

Authors:  Jaudah Al-Maghrabi
Journal:  Pak J Med Sci       Date:  2021 Jan-Feb       Impact factor: 1.088

Review 3.  Proteoglycans as Mediators of Cancer Tissue Mechanics.

Authors:  Anna Barkovskaya; Alexander Buffone; Martin Žídek; Valerie M Weaver
Journal:  Front Cell Dev Biol       Date:  2020-11-30

Review 4.  Syndecan-1 (CD138), Carcinomas and EMT.

Authors:  John R Couchman
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.